Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Prostate cancer is the most common cancer among men in the UK. Leading data and analytics company GlobalData epidemiologists ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA ...

A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...